Gates Foundation Strategic Investment Fund Logo
>
Share this page:

Portfolio

Our investments accelerate growth and stimulate private sector innovation and investment, giving our partners additional tools to effect change and improve lives. We make investments that align with foundation issue areas from vaccine development to education in the United States.

More on the types of investments we make.

Here you can explore our current and past investments, filtered by issue area or investment type.

Abbott Laboratories

Abbott Laboratories received support from the foundation to make its Panbio COVID-19 Ag Rapid Test available to low- and middle-income countries. Making high-quality, affordable rapid diagnostic tests with results available in 15-20 minutes is critical in the fight to control Read More

Gavi / Serum

The foundation has partnered with Gavi and the Serum Institute of India (“SII”) to accelerate the manufacture and delivery of up to 100 million doses of COVID-19 vaccines for low- and middle-income countries. The collaboration was expanded in August 2020 Read More

Press Release

Lilly mAb

The foundation partnered with Eli Lilly and Company to facilitate access to future Lilly therapeutic antibodies under development for the prevention and treatment of COVID-19 for low- and middle-income countries as part of the COVID-19 Therapeutics Accelerator. The COVID-19 antibodies Read More

Press Release

SD Biosensor

SD Biosensor received support from the foundation to make its COVID-19 Ag Rapid Diagnostic Test available to low- and middle-income countries. Making high-quality, affordable tests with results available in 15-30 minutes is a critical tool to fight the pandemic. Investment Read More

Press Release
Unicef Logo

UNICEF VII

The foundation provided support to expand UNICEF’s Vaccine Independence Initiative. This program allows countries to bridge-finance the procurement of vaccines while they await budget funds to be available.

Press Release

World Health Organization

The foundation’s guarantee enables WHO to secure critically-needed supplies for low- and middle-income countries in coordination with the UN Task Force for COVID by enabling WHO to issue special contracts to suppliers based on forecasted demand from countries. Investment Date: August Read More

Press Release